Dr. Andreas Boker, M.D
Mohs Surgery (MOHS-Micrographic Surgery Physician)
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 297
Licensed in Connecticut since 2021, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
MOHS-Micrographic Surgery Physician primary
NY license 262834 · CT license 67525 (first issued 2021; active) -
Procedural Dermatology Physician
NY license 262834
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Schweiger Dermatology PLLC (260 clinicians)
- Spring Street Dermatology, PLLC (11 clinicians)
- New Preston Dermatology LLC (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 297
- Services billed
- 1,855
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 728 | 102 |
| Established patient office or other outpatient visit, 20-29 minutes | 264 | 166 |
| Destruction of precancer skin growth, 1 growth | 176 | 128 |
| Biopsy of related skin growth, first growth | 129 | 110 |
| New patient office or other outpatient visit, 30-44 minutes | 106 | 106 |
| Established patient office or other outpatient visit, 10-19 minutes | 52 | 47 |
| Destruction of precancer skin growth, 15 or more growths | 50 | 39 |
| Biopsy of related skin growth, each additional growth | 43 | 32 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 42 | 37 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 41 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metronidazole Other prescribers in New York, NY | 36 |
| Minoxidil Other prescribers in New York, NY | 35 |
| Triamcinolone Acetonide Other prescribers in New York, NY | 27 |
| Clobetasol Propionate Other prescribers in New York, NY | 27 |
| Doxycycline Hyclate Other prescribers in New York, NY | 26 |
| Valacyclovir (valacyclovir hcl) Other prescribers in New York, NY | 19 |
| Fluocinolone Acetonide | 16 |
| Desonide | 16 |
| Mupirocin Other prescribers in New York, NY | 15 |
| Tacrolimus Other prescribers in New York, NY | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 33 payments worth $796 in total to this clinician.
| Incyte Corporation | $186 |
|---|---|
| Galderma Laboratories, L.P. | $99.50 |
| Arcutis Biotherapeutics, Inc. | $92.34 |
| Botanix Sb Inc | $57.14 |
| Organon LLC | $57.13 |
| Regeneron Healthcare Solutions, Inc. | $54.20 |
| AbbVie Inc. | $33.82 |
| Verrica Pharmaceuticals Inc. | $32.30 |
| Food and Beverage | $796 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.